{"id":"https://openalex.org/W54947767","doi":"https://doi.org/10.1248/yakushi1947.114.12_911","title":"Research and Development of Ozagrel, a Highly Selective Inhibitor of TXA2 Synthase","display_name":"Research and Development of Ozagrel, a Highly Selective Inhibitor of TXA2 Synthase","publication_year":1994,"publication_date":"1994-01-01","ids":{"openalex":"https://openalex.org/W54947767","doi":"https://doi.org/10.1248/yakushi1947.114.12_911","mag":"54947767","pmid":"https://pubmed.ncbi.nlm.nih.gov/7869235"},"language":"ja","primary_location":{"id":"doi:10.1248/yakushi1947.114.12_911","doi":"https://doi.org/10.1248/yakushi1947.114.12_911","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.114.12_911","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/114/12/114_12_911/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/yakushi1947/114/12/114_12_911/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110778297","display_name":"Masayuki Nakazawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119256","display_name":"Kissei Pharmaceutical (Japan)","ror":"https://ror.org/028gkfr23","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210119256"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki NAKAZAWA","raw_affiliation_strings":["Kissei Pharmaceutical Co. Ltd., Central Research Laboratories, Nagano, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kissei Pharmaceutical Co. Ltd., Central Research Laboratories, Nagano, Japan","institution_ids":["https://openalex.org/I4210119256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113435117","display_name":"Kinji Iizuka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kinji IIZUKA","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071389050","display_name":"Arao Ujiie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arao UJIIE","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006335825","display_name":"Seiji HIRAKU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seiji HIRAKU","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112274909","display_name":"Shiro Ohki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiro OHKI","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5938,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.570629,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"114","issue":"12","first_page":"911","last_page":"933"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5663999915122986,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5663999915122986,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.22280000150203705,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.1527000069618225,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ozagrel","display_name":"ozagrel","score":0.996999979019165},{"id":"https://openalex.org/keywords/thromboxane-a2-synthase-inhibitor","display_name":"thromboxane A2 synthase inhibitor","score":0.9160000085830688},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7860000133514404},{"id":"https://openalex.org/keywords/imidazole-derivatives","display_name":"imidazole derivatives","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pyridine-derivatives","display_name":"pyridine derivatives","score":0.972000002861023},{"id":"https://openalex.org/keywords/cinnamic-acid-derivatives","display_name":"cinnamic acid derivatives","score":0.765999972820282},{"id":"https://openalex.org/keywords/oky-046","display_name":"OKY-046","score":0.8119999766349792},{"id":"https://openalex.org/keywords/prostacyclin","display_name":"prostacyclin","score":0.7609999775886536},{"id":"https://openalex.org/keywords/6-keto-pgf1alpha","display_name":"6-keto-PGF1 alpha","score":0.8650000095367432},{"id":"https://openalex.org/keywords/arachidonic-acid-metabolism","display_name":"arachidonic acid metabolism","score":0.8069999814033508},{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C173202427","wikidata":"https://www.wikidata.org/wiki/Q408575","display_name":"Thromboxane-A synthase","level":4,"score":0.8643629550933838},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7326405644416809},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.6530521512031555},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.627673327922821},{"id":"https://openalex.org/C112243037","wikidata":"https://www.wikidata.org/wiki/Q22327117","display_name":"ATP synthase","level":3,"score":0.6125041246414185},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5256199240684509},{"id":"https://openalex.org/C2780978440","wikidata":"https://www.wikidata.org/wiki/Q416567","display_name":"Prostaglandin H2","level":4,"score":0.4625960886478424},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.43201518058776855},{"id":"https://openalex.org/C2778078955","wikidata":"https://www.wikidata.org/wiki/Q407699","display_name":"Arachidonic acid","level":3,"score":0.401712566614151},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.38231486082077026},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3497142493724823},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.33697831630706787},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07985657453536987},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008689","descriptor_name":"Methacrylates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008689","descriptor_name":"Methacrylates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/yakushi1947.114.12_911","doi":"https://doi.org/10.1248/yakushi1947.114.12_911","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.114.12_911","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/114/12/114_12_911/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},{"id":"pmid:7869235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7869235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","raw_type":"English Abstract"}],"best_oa_location":{"id":"doi:10.1248/yakushi1947.114.12_911","doi":"https://doi.org/10.1248/yakushi1947.114.12_911","is_oa":true,"landing_page_url":"https://doi.org/10.1248/yakushi1947.114.12_911","pdf_url":"https://www.jstage.jst.go.jp/article/yakushi1947/114/12/114_12_911/_pdf","source":{"id":"https://openalex.org/S2764386467","display_name":"YAKUGAKU ZASSHI","issn_l":"0031-6903","issn":["0031-6903","1347-5231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"YAKUGAKU ZASSHI","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W54947767.pdf","grobid_xml":"https://content.openalex.org/works/W54947767.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2343742746","https://openalex.org/W1977319687","https://openalex.org/W2057200505","https://openalex.org/W2067547769","https://openalex.org/W1982704073","https://openalex.org/W2016693231","https://openalex.org/W2042282888","https://openalex.org/W2018068140","https://openalex.org/W2950959669","https://openalex.org/W2072410689"],"abstract_inverted_index":{"Highly":[0],"selective":[1,138,203],"inhibitors":[2,48,204],"of":[3,41,49,55,63,78,91,171,201,205,211,218,233,241,244,261,287,292,299,334,340,363,372,380],"thromboxane":[4],"(TX)":[5],"A2":[6],"synthase":[7,51,220],"were":[8,52,165,386],"noted":[9],"as":[10,47,154,197,214],"a":[11],"therapeutic":[12],"agent":[13],"for":[14,96,139],"ischemic":[15,342],"heart":[16],"diseases,":[17],"thromboembolic":[18],"disorders,":[19,22],"cerebral":[20,307,328,341],"circulatory":[21],"and":[23,28,44,66,107,113,126,162,179,187,228,250,290,302,319,326,331,354,359,383],"asthma.":[24],"The":[25,38,76,131,208,216,377],"1-substituted":[26],"imidazoles":[27],"beta-substituted":[29],"pyridines":[30],"showed":[31,117],"high":[32],"inhibitory":[33,74,98],"potency":[34,99,120],"on":[35,100,182,226],"TXA2":[36,50,101,140,206,219,262,288],"synthase.":[37,102,207,263],"structure-activity":[39],"relationships":[40],"the":[42,59,73,79,83,89,97,104,118,149,169,172,176,183,198,259,281,285,297,303,321,332,338,361],"imidazole":[43,65,106],"pyridine":[45,68,108],"derivatives":[46,135],"investigated.":[53],"Introduction":[54],"various":[56,247,276,367],"substituents":[57],"into":[58,316],"carboxy-bearing":[60],"side":[61,80],"chain":[62],"1-(7-carboxyheptyl)":[64],"beta-(7-carboxyheptyl)":[67],"was":[69,86,136,195,223,272,345],"found":[70],"to":[71,93],"increase":[72,266],"potency.":[75],"length":[77],"chains":[81],"with":[82],"phenylene":[84],"group":[85],"optimum":[87],"in":[88,148,246,267,275,305,310,323,337,357,369],"region":[90],"8.5":[92],"10":[94],"A":[95],"Among":[103],"tested":[105],"derivatives,":[109],"(E)-4-(1-imidazolylmethyl)cinnamic":[110],"acid":[111,115,151,156,191],"(44)":[112],"(E)-3-[4-(3-pyridylmethyl)phenyl]-2-methylacrylic":[114],"(56)":[116],"highest":[119],"(IC50":[121],"=":[122],"1.1":[123],"x":[124,128],"10(-8)":[125],"3":[127],"10(-9)":[129],"M).":[130],"inhibition":[132,217,260],"by":[133,221,258,270,284,366,374],"these":[134],"highly":[137,202],"synthase,":[141,161],"since":[142],"other":[143,234],"enzymes":[144,230],"which":[145,312],"are":[146,213],"involved":[147],"arachidonic":[150],"cascade,":[152],"such":[153],"fatty":[155],"cyclooxygenase,":[157],"5-lipoxygenase,":[158],"prostacyclin":[159],"(PGI2)":[160],"PGE2":[163],"isomerase":[164],"not":[166],"affected.":[167],"On":[168],"basis":[170],"results":[173,379],"obtained":[174,280],"from":[175],"pharmacological,":[177],"physicochemical":[178],"toxicological":[180],"studies":[181,385],"two":[184],"compounds":[185],"(44":[186],"56),":[188],"(E)-4-(1-imidazolylmethyl)":[189],"cinnamic":[190],"(44;":[192],"OKY-046,":[193],"ozagrel)":[194],"selected":[196],"best":[199],"compound":[200],"pharmacological":[209],"properties":[210],"ozagrel":[212,222,271,295,349],"follows.":[215],"more":[224],"effective":[225],"human":[227],"rabbit":[229],"than":[231],"those":[232],"species.":[235],"Ozagrel":[236],"increased":[237],"6-keto-PGF1":[238],"alpha,":[239],"one":[240],"stable":[242],"metabolites":[243],"PGI2,":[245],"isolated":[248],"cells":[249],"tissues":[251],"perhaps":[252],"via":[253],"accumulated":[254],"PG":[255],"endoperoxides":[256],"resulted":[257],"Such":[264],"an":[265],"PGI2":[268,293],"production":[269,289],"also":[273,346,387],"observed":[274],"experimental":[277],"animals.":[278],"We":[279],"suggestion":[282],"that,":[283],"reduction":[286],"increment":[291],"production,":[294],"inhibits":[296,320,350,360],"spasms":[298],"basilar":[300],"artery":[301],"decreases":[304,322],"regional":[306,327],"blood":[308,315,329],"flow":[309],"dogs":[311],"received":[313],"autologous":[314],"cisterna":[317],"magna,":[318],"motor":[324],"function":[325],"flow,":[330],"formation":[333],"infarcted":[335],"area":[336],"animals":[339,373],"treatment.":[343],"It":[344],"suggested":[347],"that":[348],"leukotriene-,":[351],"platelet-activating":[352],"factor-,":[353],"antigen-induced":[355],"bronchoconstriction":[356],"guinea-pigs":[358],"induction":[362],"airway":[364],"hyperresponsiveness":[365],"stimuli":[368],"several":[370],"species":[371],"both":[375],"mechanisms.":[376],"summarized":[378],"ADME,":[381],"toxicological,":[382],"clinical":[384],"described.":[388]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}